Changes in cytokine production in healthy subjects practicing Guolin Qigong: A pilot study

BMC Complementary and Alternative Medicine

Volumn 1, Issue , 2001, Pages

  Jones, Brian M ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD CELL; BREATHING MECHANICS; CHINESE MEDICINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENERGY BALANCE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; IMMUNE RESPONSE; KINESIOTHERAPY; MALE; MEDITATION; MENTAL HEALTH; NORMAL HUMAN; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; SHORT COURSE THERAPY; TREATMENT OUTCOME; BIOSYNTHESIS; BLOOD; BREATHING EXERCISE; CLINICAL TRIAL; MIDDLE AGED; PILOT STUDY; REFERENCE VALUE; SECRETION;

ADULT; BREATHING EXERCISES; CYTOKINES; FEMALE; HUMANS; HYDROCORTISONE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PILOT PROJECTS; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942528870     PISSN: 14726882     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6882-1-8     Document Type: Article

References (23)

1. Chien CH, Tsuei JJ, Lee SC, Huang YC, Wei YH: Effect of emitted bioenergy on biochemical functions of cells. Am J Chin Med 1991, 19:285-292
2. Sander KM, Hu B: Medical applications of qigong and emitted qi on humans, animals, cell cultures and plants: review of selected scientific studies. Am J Acupunct 1991, 19:367-377
3. Sander KM: Medical aspects of qigong. Alternative Therapies 1996, 2:40-46
4. Wang C, Xu D, Qian Y: Medical and healthcare qigong. J Trad Chin Med 1991, 11:296-301
5. Reuther I, Aldridge D: Qigong Yangsheng as a complementary therapy in the management of asthma. J Altern Complement Med 1998, 4:173-183
6. Kuang A, Wang C, Xu D, Qian Y: Research on "anti-aging" effect of qigong. J Trad Chin Med 1991, 11:224-227
7. Ryu H, Mo HY, Mo GD, Choi BM, Jun CD, Seo CM, Kim HM, Chung HT: Delayed cutaneous hypersensitivity reactions in Qigong (chun do sun bup) trainees by multitest cell mediated immunity. Am J Chin Med 1995, 23:139-144
8. Yao BS: A preliminary study on the changes of T-cell subsets in patients with aplastic anaemia treated with qigong. Chung His I Chieh Ho Tsa Chih 1989, 9:341-342
9. Ryu H, Jun CD, Lee BS, Choi BM, Kim HM, Chung HT: Effect of qigong training on proportions of T-lymphocyte subsets in human peripheral blood. Am J Chin Med 1995, 23:27-36
10. Higuchi Y, Kotani Y, Hibuchi H, Minegishi Y, Itami J, Uh T, Manda Y: Endocrine and immune changes during Guolin New Qigong. J Intl Soc Life Info Science, 1997, 15:138
11. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357
12. Romagnani S: Lymphokine production by human T-cells in disease states. Ann Rev Immunol 1994, 12:227-257
13. Czerkinsky C, Nilsson LA, Nygren H, Ouchterlony O, Tarkowsky A: A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983, 65:109-121
14. Sedgwick JD, Holt PG: A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods 1983, 65:301-309
15. Jones BM, Kwok CCH, Kung AWC: Effect of radioactive iodine therapy on cytokine production in Graves' disease. Transient increases in interleukin-4, IL6, IL10 and tumour necrosis factor-alpha, with longer-term increases in interferon-gamma production. J Clin Endocrinol Metabol 1999, 84:4106-4110
16. Jones BM, Liu TF, Wong RWS: Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity 2000, 31:117-124
17. Jones BM, Kwok JSY, Kung AWC: Changes in cytokine production during pregnancy in patients with Graves' disease. Thyroid 2000, 10:701-707
18. Petrovsky N, McNair P, Harrison LC: Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 1998, 10:307-312
19. Petrovsky N, Harrison LC: Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T-helper type 1/T-helper type 2 balance? J Immunol 1997, 158:5163-5168
20. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol 1995, 13:251-276
21. Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ cells. Ann Rev Immunol 1994, 12:635-673
22. DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Paciotti G, Gold PW, Sternberg EM: Exercise and Circadian rhythm-induced variation in plasma cortisol regulate interleukin-1α (IL-1β), IL-6, and tumor necrosis factor-ex (TNFα) production in humans: high sensitivity of TNFα and resistance of IL-6. J Clin Endocrinol Metabol 1997, 82:2182-2191
23. Romagnani S: The Th1/Th2 paradigm. Immunol Today 1997, 18:263-266